Kuriyama K, Murakami K, Sugiura K, Sakui S, et al. One-year follow-up of the immunogenicity and safety of a first and second booster dose of the NVX-CoV2373 (TAK-019) vaccine in healthy Japanese adults who had previously received a primary series of COVID-19 mRNA vaccine: Final report of a phase 3 ope Vaccine 2025;62:127562.
PMID: 40753673